TABLE OF CONTENTS
1 INTRODUCTION 210
1.1 OBJECTIVES OF THE STUDY 210
1.2 MARKET DEFINITION 210
1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA FAT REDUCTION MARKET 210
1.4 CURRENCY AND PRICING 212
1.5 LIMITATIONS 212
1.6 MARKETS COVERED 213
2 MARKET SEGMENTATION 218
2.1 MARKETS COVERED 218
2.2 GEOGRAPHICAL SCOPE 219
2.3 YEARS CONSIDERED FOR THE STUDY 220
2.4 DBMR TRIPOD DATA VALIDATION MODEL 221
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 224
2.6 MULTIVARIATE MODELLING 225
2.7 TYPE LIFELINE CURVE 225
2.8 DBMR MARKET POSITION GRID 226
2.9 VENDOR SHARE ANALYSIS 227
2.10 MARKET APPLICATION COVERAGE GRID 228
2.11 SECONDARY SOURCES 229
2.12 ASSUMPTIONS 229
3 EXECUTIVE SUMMARY 230
4 PREMIUM INSIGHT 234
4.1 PESTEL ANALYSIS 236
4.2 PORTERS FIVE FORCES 237
4.3 MARKET ANALYSIS 238
4.4 MIDDLE EAST & AFRICA (PRICING AND PROCEDURE ANALYSIS) 239
4.4.1 SAUDI ARABIA 239
4.4.2 EGYPT 240
4.4.3 UAE 241
4.4.4 SOUTH AFRICA 242
4.4.5 ISRAEL 243
4.4.6 KUWAIT 244
4.4.7 QATAR 245
4.4.8 OMAN 246
4.4.9 BAHRAIN 247
4.4.10 LEBANON 248
4.4.11 ALGERIA 249
4.4.12 JORDAN 250
4.4.13 MOROCCO 251
4.4.14 IRAN 252
4.4.15 LIBIYA 253
4.4.16 IRAQ 254
4.4.17 TUNISIA 255
4.5 BRAND ANALYSIS 256
4.5.1 KYBELLA 256
4.5.2 AQUALYX 257
4.6 PRICING ANALYSIS (USD) 258
4.6.1 MIDDLE EAST & AFRICA 258
4.6.1.1 SAUDI ARABIA 258
4.6.1.2 EGYPT 258
4.6.1.3 UAE 258
4.6.1.4 SOUTH AFRICA 259
4.6.1.5 ISRAEL 259
4.6.1.6 KUWAIT 259
4.6.1.7 QATAR 260
4.6.1.8 OMAN 260
4.6.1.9 BAHRAIN 260
4.6.1.10 LEBANON 260
4.6.1.11 ALGERIA 261
4.6.1.12 JORDAN 261
4.6.1.13 MOROCCO 261
4.6.1.14 IRAN 261
4.6.1.15 LIBIYA 262
4.6.1.16 IRAQ 262
4.6.1.17 TUNISIA 262
4.7 PATENT ANALYSIS OF THE MIDDLE EAST & AFRICA FAT REDUCTION MARKET 263
4.8 PRICING ANALYSIS (USD) 264
4.8.1 KYBELLA 264
4.8.2 COOLSCULPTING 266
4.8.3 COOLSCULPTING ELITE 268
4.8.4 COOLTONE 270
5 INDUSTRY INSIGHTS: 273
5.1 DEMOGRAPHIC TRENDS: 274
5.2 CONCLUSION: 275
6 MIDDLE EAST & AFRICA FAT REDUCTION MARKET, REGULATIONS 276
6.1 SOUTH AFRICA 276
6.1.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE 276
6.1.2 REGULATORY APPROVAL AGENCIES 276
6.1.3 LICENSING AND REGISTRATION 276
6.1.4 POST-MARKETING SURVEILLANCE 277
6.2 SAUDI ARABIA 277
6.2.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE 277
6.2.2 REGULATORY APPROVAL AGENCIES 278
6.2.3 LICENSING AND REGISTRATION 278
6.2.4 POST-MARKETING SURVEILLANCE 278
6.2.5 GOOD MANUFACTURING PRACTICES (GMPS) GUIDELINES 278
6.3 UAE 279
6.3.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE 279
6.3.2 LICENSING AND REGISTRATION 280
6.3.3 REGULATORY APPROVAL AGENCIES 281
6.3.4 GOOD MANUFACTURING PRACTICES (GMPS) 281
6.4 EGYPT 281
6.4.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE 281
6.4.2 REGULATORY APPROVAL AGENCIES 282
6.4.3 LICENSING AND REGISTRATION 282
6.4.4 POST-MARKETING SURVEILLANCE 282
6.4.5 GOOD MANUFACTURING PRACTICES (GMPS) GUIDELINES 282
6.5 KUWAIT 282
6.5.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE 282
6.5.2 REGULATORY APPROVAL AGENCIES 283
6.5.3 LICENSING AND REGISTRATION 283
6.6 ISRAEL 283
6.6.1 REGULATORY APPROVAL PROCESS 283
6.6.2 TIMELINE 283
6.6.3 REGULATORY APPROVAL AGENCIES 283
6.6.4 LICENSING AND REGISTRATION 283
6.6.5 POST-MARKETING SURVEILLANCE 284
6.7 ALGERIA 285
6.7.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE 285
6.7.2 REGULATORY APPROVAL AGENCIES 285
6.7.3 LICENSING AND REGISTRATION 285
6.8 JORDAN 285
6.8.1 REGULATORY APPROVAL AGENCIES, PROCESS, PATHWAYS, AND TIMELINE 285
6.8.2 LICENSING AND REGISTRATION 285
6.8.3 POST-MARKETING SURVEILLANCE 285
6.9 BAHRAIN 286
6.9.1 LICENSING AND REGISTRATION 286
6.9.2 FUNDAMENTAL GUIDELINES FOR TRACEABILITY IN BAHRAIN 287
6.10 IRAQ 287
6.10.1 REGULATORY APPROVAL PROCESS, AGENCIES, FUNCTION 287
6.11 IRAN 288
6.11.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE 288
6.11.2 REGULATORY APPROVAL AGENCIES 288
6.11.3 LICENSING AND REGISTRATION 289
6.12 LEBANON 289
6.12.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE 289
6.12.2 REGULATORY APPROVAL AGENCIES 289
6.12.3 LICENSING AND REGISTRATION 289
6.13 LIBYA 290
6.13.1 REGULATORY APPROVAL AGENCIES AND FUNCTION 290
6.14 MOROCCO 290
6.14.1 REGULATORY APPROVAL AGENCIES AND FUNCTION 290
6.15 OMAN 290
6.15.1 REGULATORY APPROVAL AGENCIES AND REGISTRATION PROCESS 290
6.16 QATAR 291
6.16.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE 291
6.16.2 REGULATORY APPROVAL AGENCIES 291
6.17 TUNISIA 291
6.17.1 REGULATORY APPROVAL AGENCIES AND REGISTRATION PROCESS 291
6.17.2 GOOD MANUFACTURING PRACTICES (GMPS) GUIDELINES: 293
7 PIPELINE ANALYSIS OF THE MIDDLE EAST & AFRICA FAT REDUCTION MARKET 295
8 MARKET ACCESS 302
8.1 MANUFACTURER AND STRATEGIC DEALS 302
8.2 CURRENT TREATMENT PRACTICES 302
8.3 IMPACT OF UPCOMING THERAPY 303
9 MARKET OVERVIEW 304
9.1 DRIVERS 306
9.1.1 INCREASING DEMAND FOR MINIMALLY INVASIVE AND NON-INVASIVE PROCEDURES 306
9.1.2 GROWING AESTHETIC CONSCIOUSNESS AND BEAUTY STANDARDS 307
9.1.3 GROWING TECHNOLOGICAL ADVANCEMENTS 308
9.1.4 DECREASED DISPARITY BETWEEN MEN AND WOMEN FOR AESTHETIC PROCEDURES 309
9.2 RESTRAINTS 310
9.2.1 HIGH COST OF PROCEDURES 310
9.2.2 INCREASED RISKS ASSOCIATED WITH THE PROCEDURES 311
9.2.3 PRODUCT RECALL 311
9.3 OPPORTUNITIES 312
9.3.1 CUSTOMIZED TREATMENT PLANS AND INTEGRATION WITH OTHER AESTHETIC PROCEDURES 312
9.3.2 BELIEF AND TREND OF FAT REDUCTION IN YOUNG ADULTS 313
9.3.3 FOCUS ON INCLUSIVITY AND DIVERSITY AND EXPANSION OF PRODUCT LINES 315
9.4 CHALLENGES 317
9.4.1 LONG-TERM EFFICACY AND SUSTAINABILITY 317
9.4.2 LONGER RECOVERY TIME OF THE PROCEDURE 317
10 MIDDLE EAST & AFRICA FAT REDUCTION MARKET, BY TYPE 319
10.1 OVERVIEW 320
10.2 SURGICAL FAT REDUCTION 323
10.2.1 LIPOSUCTION 324
10.2.1.1 BY TYPE 325
10.2.1.1.1 ULTRASOUND-ASSISTED LIPOSUCTION 325
10.2.1.1.2 LASER-ASSISTED LIPOSUCTION 326
10.2.1.1.3 TUMESCENT LIPOSUCTION 326
10.2.1.1.4 SUPER-WET TECHNIQUE 326
10.2.1.2 BY APPLICATION 326
10.2.1.2.1 ABDOMINAL FAT 327
10.2.1.2.2 THIGHS FAT 327
10.2.1.2.3 BUTTOCK FAT 327
10.2.1.2.4 UPPER-ARM FAT 327
10.2.1.2.5 FACIAL FAT-DEPOSITS 327
10.2.1.2.5.1 SUBMENTAL AREAS 328
10.2.1.2.5.2 MALAR 328
10.2.1.2.5.3 MANDIBULAR 328
10.2.1.2.6 KNEE FAT 328
10.2.2 SURGICAL REJUVENATION 328
10.2.2.1 FACE LIFT 329
10.2.2.2 NECK LIFT 329
10.2.3 CHIN IMPLANT 329
10.2.3.1 SILICONE CHIN IMPLANTS 330
10.2.3.2 OTHERS 330
10.2.4 PORUS IMPLANTS 330
10.2.4.1 TEFLON 331
10.2.4.2 GORE-TEX 331
10.2.4.3 MEDPORE IMPLANTS 331
10.3 NON-INVASIVE FAT REDUCTION 331
10.3.1 CRYOLIPOLYSIS 334
10.3.1.1 COOL SCULPTING 334
10.3.1.2 COOL SCULPTING ELITE 334
10.3.1.3 COOL TONE 335
10.3.1.4 OTHERS 335
10.3.1.4.1 ABDOMINAL FAT 335
10.3.1.4.2 THIGHS FAT 335
10.3.1.4.3 BUTTOCK FAT 336
10.3.1.4.4 UPPER-ARM FAT 336
10.3.1.4.5 FACIAL FAT-DEPOSITS 336
10.3.1.4.6 KNEE FAT 336
10.3.2 ULTRASOUND 336
10.3.2.1 INTERNAL ULTRASONIC LIPOSUCTION 337
10.3.2.2 EXTERNAL ULTRASONIC LIPOSUCTION 337
10.3.2.2.1 ABDOMINAL FAT 338
10.3.2.2.2 THIGHS FAT 338
10.3.2.2.3 BUTTOCK FAT 338
10.3.2.2.4 UPPER-ARM FAT 338
10.3.2.2.5 FACIAL FAT-DEPOSITS 338
10.3.2.2.6 KNEE FAT 338
10.3.3 RADIOFREQUENCY 339
10.3.3.1 ABDOMINAL FAT 339
10.3.3.2 THIGHS FAT 339
10.3.3.3 BUTTOCK FAT 339
10.3.3.4 UPPER-ARM FAT 339
10.3.3.5 FACIAL FAT-DEPOSITS 340
10.3.3.6 KNEE FAT 340
10.3.4 LOW LEVEL LASER THERAPY 340
10.3.4.1 ABDOMINAL FAT 340
10.3.4.2 THIGHS FAT 340
10.3.4.3 BUTTOCK FAT 341
10.3.4.4 UPPER-ARM FAT 341
10.3.4.5 FACIAL FAT-DEPOSITS 341
10.3.4.6 KNEE FAT 341
10.3.5 OTHERS 341
10.4 MINIMALLY INVASIVE 341
10.4.1 INJECTION LIPOLYSIS 343
10.4.1.1 DEOXYCHOLIC ACID INJECTIONS 343
10.4.1.1.1 KYBELLA/BELKYRA 344
10.4.1.1.1.1 FACIAL FAT-DEPOSITS 345
10.4.1.1.1.2 UPPER-ARM FAT 345
10.4.1.1.1.3 ABDOMINAL FAT 345
10.4.1.1.1.4 THIGHS FAT 345
10.4.1.1.1.5 KNEE FAT 345
10.4.1.1.1.6 BUTTOCK FAT 345
10.4.1.1.2 AQUALYX 346
10.4.1.1.2.1 FACIAL FAT-DEPOSITS 346
10.4.1.1.2.2 UPPER-ARM FAT 346
10.4.1.1.2.3 ABDOMINAL FAT 346
10.4.1.1.2.4 THIGHS FAT 347
10.4.1.1.2.5 KNEE FAT 347
10.4.1.1.2.6 BUTTOCK FAT 347
10.4.1.2 PHOSPHATIDYLCHOLINE 347
10.4.1.2.1 FACIAL FAT-DEPOSITS 348
10.4.1.2.2 UPPER-ARM FAT 348
10.4.1.2.3 ABDOMINAL FAT 348
10.4.1.2.4 THIGHS FAT 348
10.4.1.2.5 KNEE FAT 348
10.4.1.2.6 BUTTOCK FAT 348
10.4.1.3 OTHERS 348
10.4.2 OTHERS 348

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.